APA Citatie

Wu, Y., Xu, J., Xu, J., Wang, Y., Wang, L., Lv, W., & Hu, J. (2020). The predictive value of tumor mutation burden for immune checkpoint inhibitors therapy in non-small cell lung cancer is affected by patients’ age. Biomark Res.

Chicago Style citaat

Wu, Yongfeng, Jinming Xu, Jiawei Xu, Yiqing Wang, Luming Wang, Wang Lv, en Jian Hu. "The Predictive Value of Tumor Mutation Burden for Immune Checkpoint Inhibitors Therapy in Non-small Cell Lung Cancer Is Affected By Patients’ Age." Biomark Res 2020.

MLA citatie

Wu, Yongfeng, et al. "The Predictive Value of Tumor Mutation Burden for Immune Checkpoint Inhibitors Therapy in Non-small Cell Lung Cancer Is Affected By Patients’ Age." Biomark Res 2020.